GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Stock Based Compensation

Curocell (XKRX:372320) Stock Based Compensation : ₩1,409.94 Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Stock Based Compensation?

Curocell's Stock Based Compensation for the six months ended in Jun. 2023 was ₩1,549.78 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was ₩1,409.94 Mil.


Curocell Stock Based Compensation Historical Data

The historical data trend for Curocell's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Stock Based Compensation Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
75.40 1,918.74 2,776.23 3,249.26 1,409.94

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Stock Based Compensation 1,801.73 1,447.52 1,549.78 -139.84

Curocell Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩1,409.94 Mil.


Curocell Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Curocell's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines